[Skip to Content]

Upstate Active Clinical Trials

Study Title:

A single-center in vitro study to evaluate GSK 1325756 inhibition of CD11b cell surface expression in healthy adults and respiratory syncytial virus-infected children <2 years

What is the purpose of the study?

We are currently studying treatment options for a respiratory infection in children caused by the virus, respiratory syncytial virus (RSV). RSV makes children very sick and we have no drugs to treat this infection. The use of the medication, GSK 1325756, to treat RSV infection will be studied in children in the next few years. The purpose of this research study is to guide appropriate dosing recommendations of this medication for future clinical trials. We will do this by studying blood samples collected from healthy adults and RSV-infected children and adding the medicine, GSK 1325756 to the samples.

Currently, we have no drugs to treat children with RSV infection. The use of the medication, GSK 1325756, to treat RSV infection will be studied in children in the next few years. The purpose of this research study is to guide appropriate dosing recommendations of this medication for future clinical trials. We will do this by studying blood samples collected from healthy adults and RSV-infected children and adding the medicine, GSK 1325756 to the samples.

Upstate Institutional Review Board (IRB) Number:

528523

Study/Protocol ID:

GSK 1325756

Patient Age Group:

Adults and Children

Principal Investigator:

Joseph B Domachowske

Who can I contact for more information?

Name: Jodi Halczyn
Phone: 315-464-1992
Email: halczynj@upstate.edu

Return to Previous Page || Search Again

Top